Live Broadcast to Explore a Newly Approved Treatment Option Available for Patients with Pretreated HR+/HER2-negative Metastatic Breast Cancer

Immunomedics, a subsidiary of Gilead Sciences

Event Details

  • Start: 30 March 2023 6:00 pm EDT
  • End: 30 March 2023 8:00 pm EDT

Register Now

  • 2 Start Times:
  • 30 March 2023 6:00 pm EDT
  • 30 March 2023 8:00 pm EDT

© 2021 FLASCO | Premium Website Design by The HDG

FLASCO